Ting-Ting Fang
Papers
1
Total Citations
142
H-Index
1
About
Ting-Ting Fang is a pioneering researcher at the intersection of synthetic biology and gastrointestinal disease, best known for engineering living therapeutics. Her landmark 2022 study, cited over 140 times, introduced a biomarker-responsive probiotic that not only diagnoses and records inflammatory bowel disease (IBD) in mice but also actively ameliorates it—a breakthrough in "smart" bacterial therapies. This work exemplifies her core contributions: designing genetically engineered microbes that sense disease-specific signals, process information, and deliver targeted treatments, effectively turning probiotics into programmable diagnostic and therapeutic platforms. Fang’s research has reshaped how we approach chronic inflammatory conditions, offering a non-invasive, real-time alternative to conventional drugs. Her impact is reflected in the rapid citation of her work, signaling its foundational role in the emerging field of living diagnostics. Beyond IBD, her innovations hold promise for other gut-linked disorders, positioning her as a leader in translating synthetic biology from bench to bedside. For students and researchers, Fang’s work is a compelling model of how interdisciplinary thinking—merging microbiology, genetic circuits, and medicine—can create transformative tools for precision health.
Research Focus
Key Achievements
Top Papers
- 1